Michael Vi / Shutterstock.com
7 July 2022Big Pharma
USPTO and FDA unite to tackle drug pricing
The US Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) have partnered to facilitate access to affordable drugs.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
9 June 2022 A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
3 August 2020 The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
6 September 2022 Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.
Editor's picks
Editor's picks
Americas
9 June 2022 A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
3 August 2020 The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
6 September 2022 Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.
Americas
9 June 2022 A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
3 August 2020 The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
6 September 2022 Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.